Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Miwu oil is an investigational **botanical oil preparation** derived from *Ligusticum chuanxiong* foliage, known in traditional Chinese medicine as 蘼芜. It was developed by Chengdu High-tech Zone Kaiyuan Pharmaceutical as an oral soft-capsule candidate for tension-type headache. A randomized, double-blind, parallel-group Phase 1 dose-escalation study in healthy volunteers evaluated single- and multiple-dose safety and tolerability; no specific molecular target or validated modern pharmacologic mechanism has been publicly disclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on miwu oil.